EHL Bio Co., Ltd.
Quick facts
Phase 3 pipeline
- ADSTEM Inj. · Regenerative Medicine / Orthopedics
ADSTEM is an allogeneic adipose-derived mesenchymal stem cell therapy that promotes tissue regeneration and modulates immune responses.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: